XML 115 R100.htm IDEA: XBRL DOCUMENT v3.24.0.1
Commitments and Contingencies - Additional Information (Detail)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 30, 2022
USD ($)
Oct. 31, 2021
USD ($)
Mar. 31, 2021
USD ($)
Oct. 31, 2018
Suite
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
Suite
Jun. 30, 2018
Suite
Jun. 30, 2018
mo
Commitments And Contingencies [Line Items]                      
Amendment Implemented Fee         $ 60.0            
Long-Term Purchase Commitment, Amount         $ 54.7            
Research and Development Expense [Member]                      
Commitments And Contingencies [Line Items]                      
Non Refundable Advance Payments           $ 2.6          
First Installments [Member]                      
Commitments And Contingencies [Line Items]                      
Installments Date of implemented fee         Mar. 01, 2024            
Amendment Implemented Fee         $ 20.0            
Thermo Fisher Scientific, Inc. [Member]                      
Commitments And Contingencies [Line Items]                      
Research and development expense           0.0 $ 54.0 $ 0.0      
CRO [Member]                      
Commitments And Contingencies [Line Items]                      
Cancellable future commitments           580.0          
CRO [Member] | Other Funding Commitments [Member]                      
Commitments And Contingencies [Line Items]                      
Expenditures incurred by CROs           $ 112.2 $ 78.7 $ 47.9      
Supply Agreement [Member] | Thermo Fisher Scientific, Inc. [Member]                      
Commitments And Contingencies [Line Items]                      
Number of dedicated clean room suites                   4 4
Agreement expiration date       Dec. 31, 2028              
Supply Agreement [Member] | Thermo Fisher Scientific, Inc. [Member] | Research and Development Expense [Member]                      
Commitments And Contingencies [Line Items]                      
Research and development expense   $ 24.4                  
Derecognition of right of use asset   23.4                  
Derecognition of lease liabilities   20.1                  
Recognition of loss   3.3                  
Non Refundable Advance Payments   $ 21.1                  
Catalent Agreements [Member]                      
Commitments And Contingencies [Line Items]                      
Recognition Of Right Of Use Asset $ 19.2                    
Increase in long-term deposits manufacturing $ 3.9                    
Catalent Agreements [Member] | Research and Development Expense [Member]                      
Commitments And Contingencies [Line Items]                      
Derecognition of right of use asset     $ 22.8                
Derecognition of lease liabilities     20.0                
Recognition of loss     $ 2.8                
Catalent Agreements [Member] | Paragon [Member]                      
Commitments And Contingencies [Line Items]                      
Number of dedicated clean room suites | Suite       2         4    
Number of additional clean room suites available on optional reserve | Suite       2              
Agreement expiration date       Dec. 31, 2024              
Clinical and Commercial Supply Agreement [Member] | Aldevron LLC [Member]                      
Commitments And Contingencies [Line Items]                      
Agreement expiration date           Dec. 31, 2026          
Agreement expiration description           The Company has the option to extend the term of the Aldevron Agreements by one year if the Company delivers a written notice of its intention to extend to Aldevron no later than June 1, 2025. Both parties have the right to early terminate without additional penalty. The Company has determined that the Aldevron Agreements do not contain an embedded lease because it does not convey the right to control the use of Aldevron’s facility or related equipment therein.